Cart
sales@molnova.com
OXFBD04
CAS No. 2231747-03-6
OXFBD04( —— )
Catalog No. M26352 CAS No. 2231747-03-6
OXFBD04 is a potent and selective inhibitor of BRD4(IC50 of 166 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 122 | In Stock |
|
| 2MG | 67 | In Stock |
|
| 5MG | 111 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 339 | In Stock |
|
| 50MG | 494 | In Stock |
|
| 100MG | 670 | In Stock |
|
| 200MG | 923 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOXFBD04
-
NoteResearch use only, not for human use.
-
Brief DescriptionOXFBD04 is a potent and selective inhibitor of BRD4(IC50 of 166 nM).
-
DescriptionOXFBD04 is a potent and selective inhibitor of BRD4(IC50 of 166 nM).(In Vitro):OXFBD04 (0.01-100 μM) inhibits the cell growth of cancer cell lines. In MCF7 breast cancer cells, OXFBD04 (10 μM) induces MYC suppression.(In Vivo):OXFBD04 has optimized physicochemical properties (LE = 0.43; LLE = 5.74; SFI = 5.96), and greater metabolic stability (t1/2 = 388 min, CLint = 3.57 μL/min/mg).
-
In VitroOXFBD04 (0.01-100 μM; 48 hours) inhibits cancer cell lines growth. OXFBD04 (10?μM; for 10, 24, or 48?hours) induces MYC suppression in MCF7 breast cancer cells. Cell Viability AssayCell Line:A498 (renal), HT-29 (colon), and MCF7 (breast) cancer cell lines Concentration:0.01, 0.1, 1, 10, 100 μM Incubation Time:48 hoursResult:Inhibited cancer cell lines growth.
-
In VivoOXFBD04 has optimised physicochemical properties (LE=0.43; LLE=5.74; SFI=5.96), and good metabolic stability (t1/2=388?min). OXFBD04 has CLint of 3.57 μL/min/mg.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorAnti-infection| Antibacterial| Antibiotic| α-glucosidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2231747-03-6
-
Formula Weight296.326
-
Molecular FormulaC17H16N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 250 mg/mL (843.68 mM)
-
SMILESCc1noc(C)c1-c1cc(O)cc(c1)C(O)c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nishida M, Murakawa T, Kamimura T, Okada N, Sakamoto H, Fukada S, Nakamoto S, Yokota Y, Miki K. In vitro and in vivo evaluation of ceftezole, a new cephalosporin derivative. Antimicrob Agents Chemother. 1976 Jul;10(1):1-13.
molnova catalog
related products
-
MS645
MS645 is an inhibitor of bromodomain-containing protein 4 (BRD4) with a Ki of 18.4 nM for BRD4-BD1/BD2.
-
GSK778 hydrochloride
GSK778 hydrochloride hydrochloride is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively.
-
PBRM1-BD2-IN-7
PBRM1-BD2-IN-7, a selective and cell-active inhibitor targeting the polybromo-1 (PBRM1) bromodomain, demonstrates inhibitory efficacy against PBRM1-BD2 with an IC50 value of 0.29 μM.
